Cytek Biosciences Inc (CTKB) Financials

$4.62

$-0.08 (-1.70%)

As on 08-Sep-2026 16:00EDT

Market cap

$611 Mln

Revenue (TTM)

$207 Mln

P/E Ratio

--

P/B Ratio

1.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	206.71	201.49	200.45	193.02	164.04	127.95
Cost of Revenue	96.68	97.03	89.35	83.59	63.06	48.81
Gross Profit	110.03	104.46	111.11	109.43	100.97	79.14
Operating Expenses	154.68	144.84	131.63	137.27	102.78	69.99
Operating Profit (EBIT)	-44.65	-40.38	-20.52	-27.85	-1.80	9.16
Other Income	--	--	--	--	5.64	0.05
Profit before Tax	-40.82	-29.84	-5.70	-15.71	1.26	5.94
Provision for Tax	39.76	36.70	0.32	-3.56	-1.22	2.91
Profit after Tax (Net Income)	-80.58	-66.54	-6.02	-12.15	2.58	3.00
Minority Interest	--	--	--	-0.19	-0.09	-0.03
Consolidated Profit	--	--	--	--	2.58	0.05

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	321.95	341.74	395.74	393.06	425.30	405.04
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	40.65	42.00	36.10	45.17	44.89	24.74
Current Liabilities	84.34	77.80	67.66	56.23	49.04	33.18
Total Liabilities	531.27	461.54	499.50	494.46	519.48	463.31

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	69.00	69.55	103.05	102.40	65.46	31.57
Current Assets	377.93	392.00	396.45	392.06	454.02	431.73
Total Assets	531.27	461.54	499.50	494.46	519.48	463.31
Total Debt*	26.46	23.74	17.02	14.14	18.09	--
Net Current Assets	293.60	314.19	328.78	335.83	404.98	399.89

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-4.69	25.38	5.28	-12.23	4.63
Cash Flow from Investing Activities	--	10.12	-82.97	-93.89	-55.91	-20.99
Cash from Financing Activities	--	-13.43	-15.82	-41.81	5.51	213.56
Net Cash Inflow / Outflow	--	--	--	--	-62.63	197.20

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.63	-0.52	-0.05	-0.09	0.02	0.03
Cash EPS ($)	--	-0.43	0.03	-0.03	0.06	0.04
Adjusted Book Value ($)	--	2.67	3.06	3.01	3.10	3.56
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.04	0.20	0.04	-0.09	0.04
Free Cash Flow per Share ($)	--	-0.07	0.17	0.00	-0.16	0.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-17.10	-1.47	-2.86	0.61	1.53
ROE (%)	-24.28	-18.05	-1.53	-2.97	0.62	1.54
ROA (%)	-14.68	-13.85	-1.21	-2.40	0.52	0.88
EBIT Margin (%)	-18.89	-14.57	-2.84	-7.07	2.34	6.00
Net Margin (%)	-38.98	-33.02	-3.00	-6.29	1.52	2.34
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	5.44	0.01	0.04	0.18	0.28	0.38
EBIT Growth (%)	-75.49	-415.21	58.21	-455.80	-50.08	-47.98
Net Profit Growth (%)	-1,158.83	-1,005.30	50.44	-571.58	-14.16	-84.54
EPS Growth (%)	-1,127.53	-10.14	0.50	-5.94	-0.29	-0.83
Book Value Growth (%)	-16.39	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-9.73	-139.29	-98.13	543.10	617.98
Price / Book Value	1.89	1.89	2.12	3.03	3.29	4.58
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	222.69	-23.54	120.61	-214.12	113.36	167.02
Close Price ($)	4.43	5.05	6.49	9.12	10.21	16.32
High Price ($)	6.18	7.30	9.33	13.77	17.41	28.70
Low Price ($)	3.09	2.37	4.66	3.80	7.38	15.91
Market Cap ($ Cr)	610.92	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.00	0.07	0.04	0.04	0.04	--
Short term debt to equity ratio	0.04	0.03	0.02	0.01	0.01	0.04
Current Ratio	4.48	5.04	5.86	6.97	9.26	13.01
Quick Ratio	3.86	4.42	5.21	5.89	8.28	12.04
Interest Coverage	-22.16	-61.96	-1.09	-6.59	1.49	4.41

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	24.82	35.80	30.23	29.08	31.01	23.16
Asset Turnover	0.38	0.42	0.40	0.38	0.33	0.37
Receivable days	--	120.29	106.33	101.24	89.63	68.14
Inventory Days	--	173.76	214.15	238.21	232.62	206.51
Payable days	--	22.47	17.50	17.12	22.70	22.37
Cash Conversion Cycle	--	271.57	302.98	322.32	299.55	252.28

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.